What is LIXT (LIXT) stock price today?

LIXT (LIXT) is currently trading at $7.21, down 6% today.

What is LIXT P/E ratio?

LIXT's P/E ratio is -5.30. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is LIXT return on equity (ROE)?

LIXT's return on equity (ROE) is -101.95%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is LIXT's market cap?

LIXT has a market capitalization of $89.11M.

NASDAQ · Biotechnology

LIXT (LIXT) Stock

$7.21 -6.00% NASDAQ: LIXT Healthcare

Valuation

Metric	Value
Price	$7.21
Market Cap	$89.11M
P/E Ratio	-5.30
P/B Ratio	7.32
P/S Ratio	0.00
EPS (TTM)	$-1.26
52-Week High	$8.09
52-Week Low	$0.68
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-101.95%
ROA	-46.00%
ROCE	-45.45%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.13
Current Ratio	5.00

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-7.0M	$-6.0M	$-5.0M	$-4.0M	$-5.0M
Net Profit	$-7.0M	$-6.0M	$-5.0M	$-4.0M	$-6.0M
EPS	$-5.00	$-4.00	$-2.66	$-1.59	$-1.26
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$5.0M	$6.0M	$4.0M	$1.0M	$13.0M
Total Liabilities	$0	$0	$0	$0	$2.0M
Cash	$5.0M	$5.0M	$4.0M	$1.0M	$5.0M
Borrowings	$0	$0	$0	$0	$1.0M

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-4.0M	$-5.0M	$-4.0M	$-3.0M	$-3.0M
Investing Cash Flow	$0	$0	$0	$0	$-3.0M
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$1.0M	$-1.0M	$-3.0M	$4.0M
Free Cash Flow	$-4.0M	$-5.0M	$-4.0M	$-3.0M	$-3.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-5.62%
Quick Ratio	2.78
Interest Coverage	—
Return 1Y	48.34%
Return 3Y	14.86%
Return 5Y	-78.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ALLRAllarity Therapeutics, Inc.	$1.00	+1.84%	-1.33	$15.91M	0.00%
BCTXBriaCell Therapeutics Corp.	$3.95	+0.77%	-0.33	$34.36M	0.00%
CASICASI Pharmaceuticals, Inc.	$0.15	+3.08%	-0.07	$2.33M	0.00%
CINGCingulate Inc.	$4.86	-0.51%	-0.95	$65.39M	0.00%
CLSDClearside Biomedical, Inc.	$0.41	+0.00%	-0.11	$2.15M	0.00%

About LIXT

LIXT is led by CEO Geordan G. Pursglove, employs 2 people, headquartered in US, publicly traded since 2007.

LIXT stock trades at $7.21 with a market capitalization of $89.11M. The stock is valued at a price-to-earnings (P/E) ratio of -5.30, price-to-book of 7.32, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.68 and $8.09, and currently trades 10.9% below its 52-week high.

On profitability, LIXT generates a return on equity (ROE) of -101.95%, return on capital employed of -45.45%, an operating margin of 0.00%, a net profit margin of 0.00%.